ligand pharmaceuticals-cl b
(LGND:NASDAQ GM)
Executive Profile*
David E. RobinsonFormer Chairman, Chief Executive Officer and President, Ligand Pharmaceuticals Incorporated |
| Age | Total Calculated Compensation | This person is connected to 105 board members in 1 different organizations across 1 different industries. See Board Relationships |
| 63 | -- |
Background*
Mr. David E. Robinson has been the President, Chief Executive Officer and a Director of Ligand Pharmaceuticals Inc. since 1991 and Chairman of the Board Since May 1996. Mr. Robinson was Chief Operating Officer at Erbamont, a pharmaceutical company from 1987 to 1990. From 1984 to 1987, Mr. Robinson was President of Adria Laboratories, Erbamont's North American subsidiary. Before joining Erbamont he was employed in various executive positions for more than 10 years by ...
Corporate Headquarters*11119 North Torrey Pines RoadLa Jolla, California 92037 United States Phone: 858-550-7500 Fax: -- Board Members Memberships*Director 1991-N/A Former Chairman, Chief Executive Officer and President
Education*MBA University Of New South Wales BA MacQuaire University
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| LGND:US | $27.38 USD | -0.36 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Frank C. Condella Jr. | Chief Executive Officer, President and Director Columbia Laboratories Inc. | $325.0K |
| Stephen M. Simes | Vice Chairman, Chief Executive Officer and President BioSante Pharmaceuticals, Inc. | $496.7K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
To contact LIGAND PHARMACEUTICALS-CL B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
